Vanguard Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
|
|||||
|
2020
Q2 | $126M | Buy |
|
|||||
|
2020
Q1 | $49.3M | Buy |
|
|||||
|
2019
Q4 | $161M | Buy |
|
|||||
|
2019
Q3 | $180M | Buy |
|
|||||
|
2019
Q2 | $162M | Buy |
|
|||||
|
2019
Q1 | $202M | Buy |
|
|||||
|
2018
Q4 | $113M | Buy |
|
|||||
|
2018
Q3 | $150M | Sell |
|
|||||
|
2018
Q2 | $214M | Buy |
|
|||||
|
2018
Q1 | $178M | Buy |
|
|||||
|
2017
Q4 | $262M | Buy |
|
|||||
|
2017
Q3 | $283M | Buy |
|
|||||
|
2017
Q2 | $259M | Sell |
|
|||||
|
2017
Q1 | $181M | Buy |
|
|||||
|
2016
Q4 | $99.2M | Buy |
|
|||||
|
2016
Q3 | $84.8M | Buy |
|
|||||
|
2016
Q2 | $85.8M | Buy |
|
|||||
|
2016
Q1 | $71.2M | Buy |
|
|||||
|
2015
Q4 | $173M | Buy |
|
|||||
|
2015
Q3 | $131M | Buy |
|
|||||
|
2015
Q2 | $136M | Buy |
|
|||||
|
2015
Q1 | $92.4M | Buy |
|
|||||
|
2014
Q4 | $60.1M | Buy |
|
|||||
|
2014
Q3 | $42M | Buy |
|
|||||
|
2014
Q2 | $39.1M | Buy |
|
|||||
|
2014
Q1 | $32.8M | Buy |
|
|||||
|
2013
Q4 | $25.2M | Buy |
|
|||||
|
2013
Q3 | $12.1M | Buy |
|
|||||
|
2013
Q2 | $353K | Buy |
|